Did CEOs and officers buy or sell their own stock?
Open-market trades by the people who know the company best, with their own money.
Last 7 days: the stocks insiders bought and sold most
Stocks Koreans hold most · disclosed Last 7 days · open-market trades only
Bought most
Sold most
Whalegun
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Disc MedicineIRON | Open-market sale10b5-1 plan | 06/26–06/29 | 06/30 | 2,500 sh2 trades | $75.00avg. | $187,500 | −4.6% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 06/26 | 06/30 | 300 sh | $72.50 | $21,750 | −0.5% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 06/22 | 06/24 | 9,700 sh | $72.66 | $704,802 | −15.2% | |
CEO | Disc MedicineIRON | Open-market sale10b5-1 plan | 06/18 | 06/23 | 34,000 sh3 trades | $70.22avg. | $2,387,328.35 | −13.1% |
Disc MedicineIRON | Open-market sale10b5-1 plan | 06/18 | 06/23 | 7,500 sh3 trades | $70.22avg. | $526,654 | −12.6% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 06/16 | 06/18 | 18,612 sh2 trades | $69.19avg. | $1,287,835.88 | −25.5% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 04/13–04/14 | 04/15 | 6,657 sh2 trades | $69.23avg. | $460,834.68 | −9.4% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 04/13 | 04/15 | 5,731 sh2 trades | $66.38avg. | $380,451.72 | −6.7% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 03/02 | 03/04 | 7,378 sh2 trades | $65.88avg. | $486,064.1 | −8.0% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 02/25 | 02/27 | 353 sh | $69.06 | $24,378.18 | −0.5% | |
Disc MedicineIRON | Open-market sale10b5-1 plan | 02/17–02/18 | 02/19 | 11,156 sh3 trades | $64.52avg. | $719,732.23 | −13.5% | |
Disc MedicineIRON | Open-market sale | 02/17 | 02/17 | 13,264 sh | $62.86 | $833,775.04 | −5.5% | |
Pamela StephensonChief Commercial Officer | Disc MedicineIRON | Open-market sale | 02/17 | 02/17 | 5,531 sh | $62.86 | $347,678.66 | −6.4% |
Disc MedicineIRON | Open-market sale | 02/17 | 02/17 | 3,231 sh | $62.86 | $203,100.66 | −5.6% | |
Rahul KharaChief Legal Officer | Disc MedicineIRON | Open-market sale | 02/17 | 02/17 | 2,853 sh | $62.86 | $179,339.58 | −5.2% |
William Jacob SavageChief Medical Officer | Disc MedicineIRON | Open-market sale | 02/17 | 02/17 | 3,256 sh | $62.86 | $204,672.16 | −3.4% |
Rahul KharaChief Legal Officer | Disc MedicineIRON | Open-market sale10b5-1 plan | 01/20 | 01/21 | 1,000 sh | $69.74 | $69,740 | −2.6% |
Disc MedicineIRON | Open-market sale10b5-1 plan | 01/02 | 01/05 | 6,500 sh3 trades | $78.68avg. | $511,449.55 | −14.7% | |
Disc MedicineIRON | Open-market sale | 25/12/17 | 25/12/18 | 754 sh3 trades | $91.47avg. | $68,968.38 | −5.1% | |
Disc MedicineIRON | Open-market sale | 25/12/12–25/12/16 | 25/12/16 | 184,123 sh19 trades | $91.56avg. | $16,858,639.38 | No record |
